Literature DB >> 12869516

Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants.

Todd D Freudenberger1, David K Madtes, J Randall Curtis, Peter Cummings, Barry E Storer, Robert C Hackman.   

Abstract

Bronchiolitis obliterans organizing pneumonia (BOOP) has been reported following hematopoietic stem cell (HSC) transplantation, but the clinical features and risk factors for this disorder have not been well characterized. This case-control study of 49 patients with histologic BOOP and 161 control subjects matched by age and year of transplantation describes the clinical features and analyzes the risk factors for BOOP following HSC transplantation. Data on clinical features and outcome were collected by chart review. Odds ratios, estimating the relative risk of BOOP in allogeneic HSC recipients, were calculated by conditional logistic regression with adjustment for potential confounding factors. Clinical features of BOOP in this population were similar to idiopathic BOOP and BOOP occurring in other disease settings. There was an association between acute and chronic graft-versus-host disease (GVHD) and the subsequent development of BOOP (odds ratios, 3.8 [95% CI, 1.2 to 12.3] and 3.1 [95% CI, 1.1 to 9.2], respectively). Patients with BOOP were more likely to have acute GVHD involving the skin (odds ratio, 4.6; P =.005) and chronic GVHD involving the gut (odds ratio, 6.6; P =.018) and oral cavity (odds ratio, 5.9; P =.026). This study shows that histologic BOOP following HSC transplantation has clinical features that resemble idiopathic BOOP and is strongly associated with prior acute and chronic GVHD. These results have important implications for the care of patients who develop respiratory symptoms after HSC transplantation and may help elucidate the pathogenesis of idiopathic BOOP.

Entities:  

Mesh:

Year:  2003        PMID: 12869516     DOI: 10.1182/blood-2002-06-1813

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  Early-onset pulmonary complication showing organizing pneumonia pattern following cord blood transplantation in adults.

Authors:  Akira Tomonari; Nobuhiro Tsukada; Satoshi Takahashi; Jun Ooi; Takaaki Konuma; Takeshi Kobayashi; Kenji Fukuno; Kashiya Takasugi; Takeshi Fujii; Tokiomi Endo; Aikichi Iwamoto; Naoki Oyaizu; Arinobu Tojo; Shigetaka Asanoa
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

2.  Influence of oral beclomethasone dipropionate on early non-infectious pulmonary outcomes after allogeneic hematopoietic cell transplantation: results from two randomized trials.

Authors:  J W Chien; M Sakai; T A Gooley; H G Schoch; G B McDonald
Journal:  Bone Marrow Transplant       Date:  2009-06-29       Impact factor: 5.483

Review 3.  An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.

Authors:  Angela Panoskaltsis-Mortari; Matthias Griese; David K Madtes; John A Belperio; Imad Y Haddad; Rodney J Folz; Kenneth R Cooke
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

4.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Authors:  Howard M Shulman; Diana M Cardona; Joel K Greenson; Sangeeta Hingorani; Thomas Horn; Elisabeth Huber; Andreas Kreft; Thomas Longerich; Thomas Morton; David Myerson; Victor G Prieto; Avi Rosenberg; Nathaniel Treister; Kay Washington; Mirjana Ziemer; Steven Z Pavletic; Stephanie J Lee; Mary E D Flowers; Kirk R Schultz; Madan Jagasia; Paul J Martin; Georgia B Vogelsang; David E Kleiner
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-29       Impact factor: 5.742

5.  Pulmonary Clinicopathological Correlation after Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series.

Authors:  Lee Gazourian; Laura Spring; Emily Meserve; David Hwang; Alejandro A Diaz; Samuel Y Ash; Vincent T Ho; Lynette M Sholl; George R Washko
Journal:  Biol Blood Marrow Transplant       Date:  2017-06-28       Impact factor: 5.742

6.  Exploring the possibilities: airspace disease in the postallogeneic haematopoietic stem cell transplant period.

Authors:  Talal Hilal; Zartash Gul
Journal:  BMJ Case Rep       Date:  2015-10-29

7.  Improvement of chronic pulmonary graft-vs-host disease manifesting as bronchiolitis obliterans organizing pneumonia following extracorporeal photopheresis.

Authors:  Basak Oyan; Yener Koc; Salih Emri; Emin Kansu
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

8.  Pleuropericarditis, obliterative bronchiolitis and lymphocytic interstitial pneumonitis after allogeneic haematopoietic stem cell transplantation.

Authors:  Amin Alousi; Somnath Ghosh; David Rice; Cesar Moran; John T Manning; Cesar Iliescu; Sharon Hymes; Stella Kim; Lara Bashoura; Steven Kornblau; Burton F Dickey
Journal:  BMJ Case Rep       Date:  2011-02-23

9.  Evaluating the impact of antithymocyte globulin on lung function at 1 year after allogeneic stem cell transplantation.

Authors:  Filippo Milano; Margaret A Au; Michael J Boeckh; H Joachim Deeg; Jason W Chien
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-22       Impact factor: 5.742

10.  Recovery of Pulmonary Function after Allogeneic Hematopoietic Cell Transplantation in Children is Associated with Improved Survival.

Authors:  Ashok Srinivasan; Anusha Sunkara; William Mitchell; Sudeep Sunthankar; Guolian Kang; Dennis C Stokes; Saumini Srinivasan
Journal:  Biol Blood Marrow Transplant       Date:  2017-09-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.